Vaccinex Total Assets from 2010 to 2024

VCNX Stock

USD 3.60 0.11 2.96%

Vaccinex Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2016-12-31

Previous Quarter

2.4 M

Current Value

4.9 M

Quarterly Volatility

8.1 M

Covid

Check Vaccinex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaccinex's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 19.7 K or Depreciation And Amortization of 181 K, as well as many indicators such as Price To Sales Ratio of 7.19, Dividend Yield of 0.0 or Days Sales Outstanding of 451. Vaccinex financial statements analysis is a perfect complement when working with Vaccinex Valuation or Volatility modules.

Check out the analysis of Vaccinex Correlation against competitors.

For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.

Latest Vaccinex's Total Assets Growth Pattern

Below is the plot of the Total Assets of Vaccinex over the last few years. Total assets refers to the total amount of Vaccinex assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vaccinex books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Vaccinex's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaccinex's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 3.63 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Vaccinex Total Assets Regression Statistics

	Arithmetic Mean	6,138,280
	Geometric Mean	4,848,994
	Coefficient Of Variation	85.55
	Mean Deviation	3,690,507
	Median	3,631,000
	Standard Deviation	5,251,020
	Sample Variance	27.6T
	Range	19.2M
	R-Value	0.41
	Mean Square Error	24.6T
	R-Squared	0.17
	Significance	0.13
	Slope	484,109
	Total Sum of Squares	386T

Vaccinex Total Assets History

	2024	6.8 M
	2023	3.6 M
	2022	8 M
	2021	9.8 M
	2020	11.7 M
	2019	4.6 M
	2018	22 M

Other Fundumenentals of Vaccinex

Intangibles To Total Assets

Vaccinex Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Long Term Debt Total	Capital Surpluse	Total Liab	Short Long Term Debt	Total Current Assets	Treasury Stock	Short Term Debt	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		-0.17	0.57	-0.65	-0.32	-0.13	-0.04	0.22	0.58	0.58	0.17	0.6	1.0	-0.1	0.62	0.12	-0.44	-0.62	0.62	0.75	0.29
Total Stockholder Equity	-0.17		0.02	-0.27	-0.07	-0.78	-0.51	-0.26	-0.28	-0.18	-0.82	-0.85	-0.17	0.15	-0.85	0.26	0.06	0.16	-0.05	0.33	0.13
Net Tangible Assets	0.57	0.02		-0.68	-0.92	-0.35	-0.67	0.62	0.79	0.94	-0.14	0.21	0.59	0.48	0.24	0.77	-0.88	-0.98	0.99	0.21	0.33
Net Debt	-0.65	-0.27	-0.68		0.49	0.59	0.35	-0.04	-0.61	-0.66	0.45	-0.14	-0.66	0.13	-0.16	-0.27	0.54	0.65	-0.7	-0.7	-0.62
Retained Earnings	-0.32	-0.07	-0.92	0.49		0.44	0.66	-0.61	-0.76	-0.84	0.14	0.02	-0.35	-0.63	-0.02	-0.93	0.95	0.89	-0.91	0.07	-0.28
Accounts Payable	-0.13	-0.78	-0.35	0.59	0.44		0.38	0.07	-0.27	-0.17	0.74	0.63	-0.14	-0.23	0.61	-0.5	0.4	0.22	-0.33	-0.38	-0.29
Long Term Debt	-0.04	-0.51	-0.67	0.35	0.66	0.38		-0.35	-0.14	-0.51	0.43	0.38	-0.06	-0.5	0.35	-0.71	0.48	0.55	-0.6	-0.01	-0.2
Net Receivables	0.22	-0.26	0.62	-0.04	-0.61	0.07	-0.35		0.51	0.56	0.0	0.27	0.23	0.71	0.29	0.53	-0.47	-0.64	0.59	-0.18	-0.43
Long Term Debt Total	0.58	-0.28	0.79	-0.61	-0.76	-0.27	-0.14	0.51		0.88	0.07	0.41	0.6	0.37	0.44	0.55	-0.87	-0.84	0.84	0.18	0.32
Capital Surpluse	0.58	-0.18	0.94	-0.66	-0.84	-0.17	-0.51	0.56	0.88		0.02	0.39	0.59	0.4	0.42	0.63	-0.87	-0.97	0.96	0.18	0.39
Total Liab	0.17	-0.82	-0.14	0.45	0.14	0.74	0.43	0.0	0.07	0.02		0.66	0.17	-0.09	0.65	-0.19	-0.03	0.0	-0.08	-0.32	-0.1
Short Long Term Debt	0.6	-0.85	0.21	-0.14	0.02	0.63	0.38	0.27	0.41	0.39	0.66		0.6	-0.28	1.0	-0.29	-0.12	-0.37	0.28	0.18	0.05
Total Current Assets	1.0	-0.17	0.59	-0.66	-0.35	-0.14	-0.06	0.23	0.6	0.59	0.17	0.6		-0.08	0.61	0.15	-0.46	-0.63	0.64	0.74	0.29
Treasury Stock	-0.1	0.15	0.48	0.13	-0.63	-0.23	-0.5	0.71	0.37	0.4	-0.09	-0.28	-0.08		-0.26	0.75	-0.53	-0.42	0.42	-0.35	-0.42
Short Term Debt	0.62	-0.85	0.24	-0.16	-0.02	0.61	0.35	0.29	0.44	0.42	0.65	1.0	0.61	-0.26		-0.26	-0.15	-0.4	0.31	0.18	0.06
Common Stock	0.12	0.26	0.77	-0.27	-0.93	-0.5	-0.71	0.53	0.55	0.63	-0.19	-0.29	0.15	0.75	-0.26		-0.84	-0.7	0.74	-0.18	0.2
Property Plant Equipment	-0.44	0.06	-0.88	0.54	0.95	0.4	0.48	-0.47	-0.87	-0.87	-0.03	-0.12	-0.46	-0.53	-0.15	-0.84		0.89	-0.9	0.0	-0.4
Current Deferred Revenue	-0.62	0.16	-0.98	0.65	0.89	0.22	0.55	-0.64	-0.84	-0.97	0.0	-0.37	-0.63	-0.42	-0.4	-0.7	0.89		-0.99	-0.18	-0.33
Net Invested Capital	0.62	-0.05	0.99	-0.7	-0.91	-0.33	-0.6	0.59	0.84	0.96	-0.08	0.28	0.64	0.42	0.31	0.74	-0.9	-0.99		0.23	0.38
Net Working Capital	0.75	0.33	0.21	-0.7	0.07	-0.38	-0.01	-0.18	0.18	0.18	-0.32	0.18	0.74	-0.35	0.18	-0.18	0.0	-0.18	0.23		0.32
Capital Stock	0.29	0.13	0.33	-0.62	-0.28	-0.29	-0.2	-0.43	0.32	0.39	-0.1	0.05	0.29	-0.42	0.06	0.2	-0.4	-0.33	0.38	0.32

Click cells to compare fundamentals

About Vaccinex Financial Statements

Vaccinex investors use historical fundamental indicators, such as Vaccinex's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Vaccinex. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	3.6 M	6.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

Additional Tools for Vaccinex Stock Analysis

When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC